(To be Published in the Gazette of India Extraordinary Part-II, Section - 3, Sub-Section (ii))

Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Udyog Bhawan
New Delhi

Notification No. 50 /2015-2020
New Delhi, Dated: 10^th January, 2022

Subject: - Amendment in Export Policy of Enoxaparin (formulation and API) and Intra-Venous Immunoglobulin (IVIG) (formulation and API) - regarding

S.O. (E) In exercise of powers conferred by Section 3 read with Section 5 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy. 2015-20, the Central Government hereby makes the following amendment in Chapter 29 and 30 of Schedule 2 of the ITCHS Export policy 2018 related to export of Enoxaparin and Intra-Venous Immunoglobulin (IVIG):

2. Effect of this Notification:

The export of Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) falling under the ITC (HS) Codes specified above or falling under any other HS Code has been put under restricted category, with immediate effect.

10/01/2022
(Amit Yadav)
Director General of Foreign Trade
Ex-Officio Additional Secretary. Government of India
E-mail: dgft@nic.in

(Issued from File No. 01/91/180/021/AM22/EC/E-30431)

1. Substituted Vide Notification No. 56/2015-2020 Dated 24.02.2022